Dental Care Clinics in Oakhurst, CA Accepting Medicare
4 Dental Care Clinics found. Showing 1 - 4
 Yosemite Dental Care Dentist Medicare: Not Enrolled in Medicare Practice Location: 49722 Road 426, Suite 104, Oakhurst, CA 93644 Phone: 559-683-4662 |
Adrian Buca, Dds, Inc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 49386 Road 426, Oakhurst, CA 93644 Phone: 559-683-6200 Fax: 559-641-6316 |
Camarena Health Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 49127 Road 426 Ste 1, Oakhurst, CA 93644 Phone: 559-664-4000 Fax: 559-675-5625 |
Miller Skinner And Dastrup Dental Corporation Of Oakhurst Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 49386 Road 426, Oakhurst, CA 93644 Phone: 559-656-6200 Fax: 844-800-0163 |
News Archive
State of Ohio selects Accenture to build new integrated eligibility system
Accenture has been selected by the State of Ohio, following a competitive bid process, to build a new integrated eligibility system for health and human service programs.
American Forests, ACTIVATE partner to celebrate Earth Month
ACTIVATE, the innovative, enhanced vitamin beverage ideal for people with active lifestyles, today announced it will extend its sustainability efforts and partner with American Forests to celebrate Earth Month through a unique "Plant a Tree" in-store initiative.
ACS webinar on chemistry for food safety
Scheduled for Thursday, April 1, 2 - 3 p.m. Eastern Time, the free webinar will feature Walter Hammack with the Florida Department of Agriculture, as he discusses the various chromatographic tools, methods and regulations for food safety. His topic: "How Chemistry is Keeping Your Food Safe -Application of Ultra High Pressure Liquid Chromatography (UHPLC) in a Food Safety Laboratory."
Bellicum Pharmaceuticals starts phase I/II trial of novel advanced prostate cancer vaccine
Bellicum Pharmaceuticals, Inc. today announced dosing of the first patient in a Phase I/II clinical trial of BP-GMAX-CD1, a novel pharmacologically regulated dendritic cell vaccine for the treatment of prostate cancer. The disease-specific trial is being conducted under a Bellicum Investigational New Drug application allowed by the FDA in 2008. The company anticipates reporting initial results of the study in 2010.
› Verified 9 days ago